No Data
Catalent Gains Amid Report Buyer Working on Contact Extensions With Drugmakers
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
CDMO Market Opportunities and Competitive Landscape Report 2024, With Profiles of Thermo Fisher Scientific, Merck, Lonza, Catalent and WuXi AppTec
How to adjust the new national medical insurance catalog? Here is the explanation.
1. The success rate is 76%, with an average decline of 63%. This year, the success rate and decline of negotiating/bidding pharmaceuticals are basically equivalent to previous years; 2. This year, the fund calculation will pay more attention to the impact on fund expenditure, while also enhancing the comprehensiveness and scientific nature of the calculation work; 3. This year's catalog adjustment places more emphasis on the actual clinical needs and patients' actual medication, highlighting support for true innovation.
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
European Equities Close Lower in Tuesday Trading
